Noevir Holdings Co., Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2018; Provides Earnings Forecast for the Half Year of the Fiscal Year Ending Sept. 30, 2019; Provides Earnings Forecast for the Full Year of the Fiscal Year Ending Sept. 30, 2019; Provides Dividend Forecast for the Fourth Quarter of Fiscal Year Ending Sept. 30, 2019
February 11, 2019 at 09:16 pm EST
Share
Noevir Holdings Co., Ltd. announced unaudited consolidated earnings results for the first quarter ended December 31, 2018. For the quarter, the company reported Net Sales were ¥16,226 million against ¥15,400 million a year ago. Operating income was ¥4,021 million against ¥3,908 million a year ago. Net income attributable to owners of parent was ¥1,555 million against ¥1,114 million a year ago. Earnings per share was ¥45.53 against ¥32.05 a year ago.
The company provides earnings forecast for the half year of the fiscal year ending Sept. 30, 2019. For the period, the company forecasts net sales of ¥29,700 million, operating income of ¥2,900 million, ordinary income of ¥600 million, net income attributable to owners of parent of ¥2,500 million and earnings per share of ¥73.19.
The company provides earnings forecast for the full year of the fiscal year ending Sept. 30, 2019. For the period, the company forecasts net sales of ¥59,500 million, operating income of ¥11,700 million, ordinary income of ¥11,900 million, net income attributable to owners of parent of ¥8,000 million and earnings per share of ¥234.22.
The company provides dividend forecast for the fourth quarter of fiscal year ending Sept. 30, 2019. For the fourth quarter, company forecasts dividend of ¥180 per share.
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
Noevir Holdings Co., Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2018; Provides Earnings Forecast for the Half Year of the Fiscal Year Ending Sept. 30, 2019; Provides Earnings Forecast for the Full Year of the Fiscal Year Ending Sept. 30, 2019; Provides Dividend Forecast for the Fourth Quarter of Fiscal Year Ending Sept. 30, 2019
NOEVIR HOLDINGS CO., LTD. 
